I agree- BLRX looks intriguing and I will be doing further research on this one. Looks like they reacquired the rights to the lead candidate from Cypress after the Cypress activist shareholder/Royalty Pharma buyout (less than a year after signing license deal with BioLineRx)
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.